Nexstim

Nexstim is a Finnish medical technology company founded in 2000, specializing in non-invasive brain stimulation technology. The company offers advanced 3D navigation for precise targeting of transcranial magnetic stimulation (nTMS). With subsidiaries in the United States and Germany, Nexstim serves universities, teaching hospitals, clinics, and research facilities worldwide. The core product line includes the Navigated Brain Stimulation (NBS) systems, which are utilized for both diagnostic and therapeutic purposes. These systems enable personalized brain mapping and treatment, accurately locating critical brain functions for neurosurgical planning. The NBS systems have received FDA approval and CE marking for presurgical mapping and treatment of major depressive disorder and chronic neuropathic pain. Nexstim emphasizes technological leadership and ease of use, aiming to improve patient outcomes through innovative solutions in neurology and psychiatry.

• Employees 40
• Founded 2000
• Annual Revenue $9100000
• Total Funding $13755666